Compare Stocks: FMS, LH, DGX, and GH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$239.60 -0.5%	$226.44	$171.18 ▼ $247.19	$26.44B	0.55	955,444 shs	1.04 million shs
FMS Fresenius Medical Care AG & Co. KGaA	$22.45 -0.9%	$23.89	$20.02 ▼ $27.64	$12.06B	0.76	690,387 shs	648,591 shs
GH Guardant Health	$161.04 -1.2%	$159.29	$53.40 ▼ $176.58	$21.61B	1.57	2.28 million shs	1.19 million shs
LH Labcorp	$331.40 -0.1%	$304.49	$244.52 ▼ $341.80	$26.88B	0.88	677,900 shs	520,641 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+2.02%	-1.66%	+3.78%	+22.72%	+34.97%
FMS Fresenius Medical Care AG & Co. KGaA	-0.29%	-3.30%	-10.56%	+3.47%	-6.85%
GH Guardant Health	-0.82%	-4.60%	+2.66%	+22.55%	+145.17%
LH Labcorp	+1.52%	-1.08%	+8.10%	+27.37%	+21.27%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$239.60 -0.5%	$226.44	$171.18 ▼ $247.19	$26.44B	0.55	955,444 shs	1.04 million shs
FMS Fresenius Medical Care AG & Co. KGaA	$22.45 -0.9%	$23.89	$20.02 ▼ $27.64	$12.06B	0.76	690,387 shs	648,591 shs
GH Guardant Health	$161.04 -1.2%	$159.29	$53.40 ▼ $176.58	$21.61B	1.57	2.28 million shs	1.19 million shs
LH Labcorp	$331.40 -0.1%	$304.49	$244.52 ▼ $341.80	$26.88B	0.88	677,900 shs	520,641 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+2.02%	-1.66%	+3.78%	+22.72%	+34.97%
FMS Fresenius Medical Care AG & Co. KGaA	-0.29%	-3.30%	-10.56%	+3.47%	-6.85%
GH Guardant Health	-0.82%	-4.60%	+2.66%	+22.55%	+145.17%
LH Labcorp	+1.52%	-1.08%	+8.10%	+27.37%	+21.27%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.54	Moderate Buy	$235.31	-1.79% Downside
FMS Fresenius Medical Care AG & Co. KGaA	1.55	Reduce	$23.57	4.97% Upside
GH Guardant Health	2.96	Moderate Buy	$183.78	14.12% Upside
LH Labcorp	2.75	Moderate Buy	$330.00	-0.42% Downside

Current Analyst Ratings Breakdown

Latest FMS, LH, DGX, and GH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2026	GH Guardant Health	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$195.00
8/25/2026	GH Guardant Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/12/2026	DGX Quest Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (B+) ➝ Buy (A-)
8/10/2026	LH Labcorp	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$355.00
8/6/2026	FMS Fresenius Medical Care AG & Co. KGaA	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Perform	$25.50 ➝ $25.80
8/5/2026	FMS Fresenius Medical Care AG & Co. KGaA	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
8/4/2026	FMS Fresenius Medical Care AG & Co. KGaA	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
8/4/2026	GH Guardant Health	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$170.00 ➝ $195.00
8/4/2026	GH Guardant Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$135.00 ➝ $193.00
8/4/2026	GH Guardant Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$175.00 ➝ $185.00
8/4/2026	LH Labcorp	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$300.00 ➝ $309.00

(Data available from 9/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$11.04B	2.40	$15.39 per share	15.57	$70.84 per share	3.38
FMS Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$5.49 per share	4.09	$29.29 per share	0.77
GH Guardant Health	$982.02M	22.01	N/A	N/A	($1.66) per share	-97.01
LH Labcorp	$13.95B	1.93	$25.13 per share	13.19	$106.13 per share	3.12

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$992M	$9.42	25.44	20.02	2.16	9.18%	16.01%	7.27%	10/20/2026 (Estimated)
FMS Fresenius Medical Care AG & Co. KGaA	$1.11B	$1.93	11.63	9.55	4.22	4.83%	9.28%	4.16%	11/3/2026 (Estimated)
GH Guardant Health	-$416.28M	-$3.49	N/A	N/A	N/A	-38.33%	N/A	-25.40%	10/28/2026 (Estimated)
LH Labcorp	$876.50M	$12.09	27.41	16.82	1.86	6.99%	16.74%	7.81%	10/27/2026 (Estimated)

Latest FMS, LH, DGX, and GH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/3/2026	Q2 2026	FMS Fresenius Medical Care AG & Co. KGaA	$0.6160	$0.66	+$0.0440	$0.46	$5.48 billion	$5.55 billion
7/30/2026	Q2 2026	GH Guardant Health	-$0.7618	-$0.42	+$0.3418	-$0.90	$314.23 million	$334.98 million
7/30/2026	Q2 2026	LH Labcorp	$4.78	$4.99	+$0.21	$3.64	$3.71 billion	$3.73 billion
7/23/2026	Q2 2026	DGX Quest Diagnostics	$2.82	$3.12	+$0.30	$2.84	$2.97 billion	$3.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.44	1.43%	+7.34%	36.52%	14 Years
FMS Fresenius Medical Care AG & Co. KGaA	$0.61	2.69%	+2.66%	31.61%	N/A
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	0.87%	N/A	23.82%	N/A

Latest FMS, LH, DGX, and GH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	DGX Quest Diagnostics	quarterly	$0.86	1.45%	10/6/2026	10/6/2026	10/21/2026
7/9/2026	LH Labcorp	quarterly	$0.72	0.86%	8/28/2026	8/28/2026	9/11/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.72	1.59	1.46
FMS Fresenius Medical Care AG & Co. KGaA	0.43	1.07	0.75
GH Guardant Health	N/A	4.03	3.71
LH Labcorp	0.69	1.80	1.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
FMS Fresenius Medical Care AG & Co. KGaA	8.37%
GH Guardant Health	92.60%
LH Labcorp	95.94%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	0.88%
FMS Fresenius Medical Care AG & Co. KGaA	N/A
GH Guardant Health	5.60%
LH Labcorp	0.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	57,000	110.37 million	109.40 million	Optionable
FMS Fresenius Medical Care AG & Co. KGaA	1,488	537.13 million	N/A	Optionable
GH Guardant Health	2,506	134.20 million	126.68 million	Not Optionable
LH Labcorp	71,000	81.10 million	80.42 million	Optionable

FMS, LH, DGX, and GH Headlines

Recent News About These Companies

Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock

September 2 at 10:51 AM | zacks.com

Public Employees Retirement System of Ohio Purchases Shares of 27,828 Labcorp Holdings Inc. $LH

September 2 at 4:48 AM | marketbeat.com

Ironvine Capital Partners LLC Has $15.35 Million Stock Holdings in Labcorp Holdings Inc. $LH

September 2 at 4:15 AM | marketbeat.com

Labcorp stock steady as guidance and earnings frame 2026 outlook

August 31 at 7:30 PM | ad-hoc-news.deA

Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity

August 31 at 7:00 AM | prnewswire.com

Labcorp Holdings Inc. $LH Shares Sold by Wellington Management Group LLP

August 31 at 5:28 AM | marketbeat.com

Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference

August 28, 2026 | prnewswire.com

Labcorp Holdings (LH) Unveiled The First FDA Cleared Single Biomarker Alzheimer’s Blood Test

August 28, 2026 | finance.yahoo.com

Are Wall Street analysts bullish on Labcorp Holdings stock?

August 26, 2026 | msn.com

Councilmark Asset Management LLC Makes New Investment in Labcorp Holdings Inc. $LH

August 26, 2026 | marketbeat.com

Labcorp (NYSE:LH) Sets New 12-Month High - Here's Why

August 26, 2026 | americanbankingnews.com

Should You Continue to Hold Labcorp Stock in Your Portfolio?

August 25, 2026 | zacks.com

Labcorp's Alzheimer's Disease Blood Test Cleared by FDA

August 24, 2026 | finance.yahoo.com

Labcorp (NYSE:LH) Hits New 12-Month High - What's Next?

August 24, 2026 | marketbeat.com

Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings

August 24, 2026 | prnewswire.com

Bank of New York Mellon Corp Invests $142.12 Million in Labcorp Holdings Inc. $LH

August 24, 2026 | marketbeat.com

Weitz Investment Management Inc. Buys New Position in Labcorp Holdings Inc. $LH

August 23, 2026 | marketbeat.com

Madison Asset Management LLC Makes New Investment in Labcorp Holdings Inc. $LH

August 20, 2026 | marketbeat.com

20,883 Shares in Labcorp Holdings Inc. $LH Purchased by Great Lakes Advisors LLC

August 20, 2026 | marketbeat.com

Labcorp (NYSE:LH) Director Sells $954,060.00 in Stock

August 18, 2026 | marketbeat.com

Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health

August 18, 2026 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS, LH, DGX, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

$239.60 -1.20 (-0.50%)

As of 03:58 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$22.45 -0.20 (-0.88%)

As of 03:58 PM Eastern

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Guardant Health NASDAQ:GH

$161.04 -2.02 (-1.24%)

As of 04:00 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Labcorp NYSE:LH

$331.40 -0.26 (-0.08%)

As of 03:58 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FMS, LH, DGX, and GH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FMS, LH, DGX, and GH Earnings

Compare Dividends

Latest FMS, LH, DGX, and GH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FMS, LH, DGX, and GH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS, LH, DGX, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

Guardant Health NASDAQ:GH

Labcorp NYSE:LH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FMS, LH, DGX, and GH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FMS, LH, DGX, and GH Earnings

Compare Dividends

Latest FMS, LH, DGX, and GH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FMS, LH, DGX, and GH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS, LH, DGX, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

Guardant Health NASDAQ:GH

Labcorp NYSE:LH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools